Vyome logo

Vyome

HIND | NASDAQ
Chart Builder DCF Calculator
$1.53
-$0.05 (-3.16%)
At close: Nov 16, 2026, 4:00 PM ET
$1.55
+$0.02 (+1.31%)
After-hours: Nov 16, 2026, 7:40 PM ET
-3.16%

Rating

Updated: Nov 16, 2026
51.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #250/1021 (Top 24%)

Key Statistics

Market Data

Market Cap $10.74M
1D Range
1.50 1.65
52W Range
1.50 5.73

Valuation (TTM)

PE -2.51
PB 2.02
EV/EBITDA -1.06

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $3.50
Loading financial charts...

Profile

Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflamm...

Sector Healthcare
Industry Biotechnology
Employees 18
IPO Date Oct 6, 2016
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$0.13
Beat +27.78%
REV
$58K
Miss -42.00%
Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.